I’m really pleased to have had my review of the Court of Justice’s seminal UsedSoft v. Oracle decision published by the prestigious Society for Computers and Law. Click the image to go there.
Posts Tagged ‘patents’
With thanks to my good friend Dr. Michael Cohen, I came across an article in the New York Times about yesterday’s FTC report into the interplay of drug patents, litigation, business and competition. The report is some 270 pages long, so I’m not going to be reading it any time soon, but the central allegation [...]
In a decision that is already attracting plenty of controversy, comments, compliments and complaints, the Court of Appeals for the Federal Circuit has held that isolated human DNA molecules are patentable, and were validly patented by Myriad, under the (US) Patents Act. See Association for Molecular Pathology et al. v. Myriad Genetics, Inc et al. (Case [...]
Microsoft’s recent (US) Supreme Court defeat at the hands of Canada’s i4i will cost them almost US$300m in damages for willful infringement of the latter’s XML patent. But in the longer term, the Court’s refusal to lower the burden of proof in challenges to a patent’s validity is good news for businesses with important patent [...]
After what seems like an eternity, the US Supreme Court today handed down its decision in Bilski vs. Kappos, on the patentability of various business methods. At first sight the decision does not seem to provide the overhaul of US patent law that many had been predicting. Much discussion will follow, so watch this space [...]
I’m taking a quick break from the busyness of 5th Avenue, New York City, to stop into Barnes & Noble and have a look around for any new reference materials. After making my way through a large group of tourists, complete with large backpacks and umbrellas, I found what I was looking for: books relating [...]